CapsoVision to release Q1 2026 financial results on May 14
A conference call and webcast will follow at 1:30 pm PT that day.
See the latest news and media coverage for Capsovision. We track all announcements, press releases, and industry mentions in real time, all in one place.
Capsule endoscopy system provider
capsovision.comLast updated
In short: CapsoVision reported stable Q1 2026 revenue of $2.8 million and prepared for midyear FDA clearance of its AI-assisted reading module.
A conference call and webcast will follow at 1:30 pm PT that day.
Revenue grew 13% in Q4 and 15% for the year, with new accounts up 16% and 21% respectively.
The proceeds will be used for general corporate purposes, including sales, marketing, and R&D.
Results after market close; conference call and webcast at 4:30 pm ET.
Joanne Imperial, a director at CapsoVision, Inc. (CV), reported a sale of company common stock on June 8, 2026. The transaction involved the disposition of...
CapsoVision (NASDAQ:CV) reported steady first-quarter revenue and said it continues to advance artificial intelligence and capsule endoscopy programs aimed at expanding the use of its...
"CapsoVision remains focused on advancing earlier, more accurate and more accessible detection of gastrointestinal disease for patients worldwide," said Co-Founder, President, CEO & Director Kang...
SARATOGA, Calif., March 12, 2026 (GLOBE NEWSWIRE)-- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions ...
Track Capsovision and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.